Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKerry Regulatory News (KYGA)

Share Price Information for Kerry (KYGA)

Share Price is delayed by 15 minutes
Get Live Data
72.50    0.00 (0.00%)
Bid:
72.40
Ask:
72.80
Spread: 0.40 (0.552%)
Market Cap: €11.59b
KYGA Live PriceLast checked at - London Stock Exchange

Intraday Kerry Share Chart

Transaction in Own Shares

6 May 2025 07:00

RNS Number : 3263H
Kerry Group PLC
06 May 2025
 

 

 

 

6 May 2025

 

LEI: 635400TLVVBNXLFHWC59

 

KERRY GROUP PLC

Regulatory Announcement

TRANSACTION IN OWN SHARES

Kerry Group plc ("Kerry" or the "Company") announces that on Friday, May 2, 2025  it purchased the following number of its A ordinary shares of €0.125 each (the "Ordinary Shares") on Euronext Dublin from J&E Davy. The Ordinary Shares purchased will be cancelled.

Euronext Dublin

 

Number of Ordinary Shares purchased: 

13,021

 

Highest price paid per Ordinary Share:

95.0000

 

Lowest price paid per Ordinary Share:

94.7000

 

Volume weighted average price paid per Ordinary Share:

94.8440

 

 

The Ordinary Shares purchased form part of Kerry's intention to buyback Ordinary Shares of a total value of up to €300 million in the period up to 30 June 2025 ("Buyback Programme"). The intention to launch this Buyback Programme was announced on 24 October 2024 and formally commenced on 12 November 2024.

Following settlement of the above transactions and subsequent share cancellation Kerry will have  164,833,979 Ordinary Shares in issue (excluding treasury shares).

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the "Market Abuse Regulation") (including as it forms part of retained EU law in the United Kingdom ('UK') from time to time and, where relevant, pursuant to the UK's European Union (Withdrawal) Act 2018 and the UK's Market Abuse (Amendment) (EU Exit) Regulations 2019), a detailed breakdown of individual trades made by J&E Davy as riskless principal on behalf of Kerry on Euronext Dublin as part of the Buyback Programme for subsequent repurchase by the Company is scheduled to this announcement.

 

CONTACT INFORMATION

 

 

 

 

Group Secretary

 

 

 

Ronan Deasy

 

 

 

+353 66 7182000 | TraleeCoSec@kerry.ie

 

 

 

 

Website

 

 

 

www.kerry.com

 

 

 

 

 

 

Issuer name:

Kerry Group plc

 

LEI

635400TLVVBNXLFHWC59

ISIN:

IE0004906560

Intermediary name:

J&E Davy

Intermediary code:

DAVYIE21

Time zone:

GMT

Currency:

EUR

Aggregated Information

Trading venue

Currency

Volume Weighted Average Price

Aggregated volume

Euronext Dublin

EUR

94.8440

13,021

Euronext Dublin

Number ofShares

Price per Share (EUR)

Trading Venue

Time of Transaction

MatchID

6771

94.700

Euronext Dublin

 08:23:02

00044384758TRLO0-1

6250

95.000

Euronext Dublin

 10:02:39

00044387825TRLO0-1

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSATMFTMTAMBIA
Date   Source Headline
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20243:09 pmRNSBlock listing Interim Review
2nd Jan 202410:27 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20234:31 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20234:13 pmRNSKerry to acquire Lactase Enzymes Business
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 202311:03 amRNSDirectorate Change
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20234:52 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20239:33 amRNSTotal Voting Rights
1st Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
20th Nov 202310:16 amRNSHolding(s) in Company
20th Nov 20237:00 amRNSTransaction in Own Shares
17th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20237:00 amRNSTransaction in Own Shares
15th Nov 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.